Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nano Regulatory News (ONT)

Share Price Information for Oxford Nano (ONT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 97.90
Bid: 98.60
Ask: 98.90
Change: -0.55 (-0.56%)
Spread: 0.30 (0.304%)
Open: 99.60
High: 102.10
Low: 97.90
Prev. Close: 98.45
ONT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Incentive Plan, Director/PDMR Transactions

13 Oct 2021 18:20

RNS Number : 0108P
Oxford Nanopore Technologies plc
13 October 2021
 

13 October 2021

Oxford Nanopore Technologies plc (the "Company")

Share Incentive Plan

The Company announces that on 13 October 2021, it issued 406,386 ordinary shares of £0.0001 each to Solium Trustee (UK) Limited at a price of £0.0001 per share. The shares were issued in satisfaction of free share awards made to eligible participants under the Oxford Nanopore Technologies plc Share Incentive Plan (the "SIP"), including those Persons Discharging Managerial Responsibility of the Company (each a "PDMR") outlined below. The shares rank equally with existing issued ordinary shares.

Eligible employees have been granted 633 free shares each, representing approximately £3,600 which is the maximum amount permitted under the relevant legislation. The free shares were awarded on 13 October 2021 and are subject to a 3-year forfeiture period. 

Details of the free shares allotted to PDMRs under the SIP are set out below:

Name of PDMR

Number of Free Shares

Gurdial (Gordon) Sanghera (Director)

633

Clive Brown (Director)

633

Timothy Cowper (Director)

633

 

This announcement is made pursuant to the Company's obligations under Article 19(3) of the UK Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Clive Brown - award of free shares under the Share Incentive Plan

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies PLC

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares with a nominal value of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award of free shares under the Company's Share Incentive Plan

c)

Price

 

Volume

 

Total

Nil

 

633

 

Nil

 

d)

Aggregated Price

 

Aggregated volume

 

Aggregated Total

N/A

 

e)

Date of the transaction

13 October 2021

f)

Place of the transaction

London Stock Exchange (XLON)

 

Timothy Cowper - award of free shares under the Share Incentive Plan

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies PLC

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares with a nominal value of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award of free shares under the Company's Share Incentive Plan

c)

Price

 

Volume

 

Total

Nil

 

633

 

Nil

 

d)

Aggregated Price

 

Aggregated volume

 

Aggregated Total

N/A

 

e)

Date of the transaction

13 October 2021

f)

Place of the transaction

London Stock Exchange (XLON)

 

Gurdial (Gordon) Sanghera - award of free shares under the Share Incentive Plan

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gurdial Sanghera

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial/Amendment notification

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies PLC

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares with a nominal value of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award of free shares under the Company's Share Incentive Plan

c)

Price

 

Volume

 

Total

Nil

 

633

 

Nil

 

d)

Aggregated Price

 

Aggregated volume

 

Aggregated Total

N/A

 

e)

Date of the transaction

13 October 2021

f)

Place of the transaction

London Stock Exchange (XLON)

 

For further information, please contact:

Oxford Nanopore Technologies plc

media@nanoporetech.com

Tulchan Group (communications adviser to the Company)

Tom Murray, Olivia Peters, Deborah Roney

+44 (0) 20 7353 4200 OxfordNanopore@tulchangroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPGAGUUPGGMW
Date   Source Headline
2nd Oct 20234:00 pmRNSIssue of Equity and Total Voting Rights
27th Sep 20235:00 pmRNSDirector Declaration
12th Sep 20233:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Sep 20237:00 amRNSPresentation at the Morgan Stanley Conference
6th Sep 20237:00 amRNSInterim results for the 6 months ended 30 June 23
1st Sep 20233:00 pmRNSIssue of Equity and Total Voting Rights
25th Aug 202312:00 pmRNSNotice of Results and Capital Markets Day
11th Aug 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20235:30 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20237:00 amRNSHalf Year Trading Update
13th Jul 20233:30 pmRNSKate Priestman appointed as Non-Executive Director
11th Jul 20235:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
3rd Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
13th Jun 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Jun 20233:30 pmRNSResult of AGM
12th Jun 20237:00 amRNSNational German rare disease study
9th Jun 20237:00 amRNSChange of Broker
1st Jun 20233:00 pmRNSIssue of Equity and Total Voting Rights
19th May 20237:00 amRNSLondon Calling Technology Update
12th May 20231:30 pmRNSHolding(s) in Company
12th May 20238:35 amRNSNext step of PathoQuest strategic collaboration
11th May 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Notification
2nd May 20233:00 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM
17th Apr 20237:00 amRNSNew infectious disease partnership with bioMerieux
13th Apr 20236:00 pmRNSDirector/PDMR Shareholding
12th Apr 20234:00 pmRNSLTIP and DBP; Director/PDMR Notification
12th Apr 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Apr 20237:00 amRNSNIH Alzheimers study shows scaled, accurate data
6th Apr 20234:00 pmRNSBlock listing Interim Review
3rd Apr 20233:30 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20237:00 amRNSNIHR, Oxford Nanopore announce new health study
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
13th Mar 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Mar 20237:00 amRNSNotice of Results
1st Mar 20233:30 pmRNSIssue of Equity and Total Voting Rights
27th Feb 20236:00 pmRNSChanges to Director Roles and Responsibilities
13th Feb 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Feb 20234:30 pmRNSTotal Voting Rights and Issue of Equity
17th Jan 20237:00 amRNSTrading update
13th Jan 20233:30 pmRNSDirector/PDMR Shareholding (ESPP)
11th Jan 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th Jan 20235:30 pmRNSDirector/PDMR Shareholding (ESPP)
3rd Jan 20235:00 pmRNSIssue of equity and Total Voting Rights
28th Dec 20223:00 pmRNSHolding(s) in Company
23rd Dec 202212:00 pmRNSHolding(s) in Company
13th Dec 20224:50 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Dec 20223:00 pmRNSIssue of Equity and Total Voting Rights
11th Nov 20224:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.